A small molecule discovery platform that allows for ultra-high-throughput synthesis of large and diverse small molecule libraries to be directly screened for activity. BRT is a novel small molecule drug discovery platform accelerating hit identification.
SH committed $100K, via StoryHouse Fund I, at a $2M valuation, in a $370K round, alongside TBA.
RAW NOTES: \- Submitted their first non-dilutive grant funding (ARPA); they may or may not be able to compete, and they'll know in 6 weeks which will tell them whether they're eligible to compete. $3.5M, they'll know if they win it in six months. Ari's contact helped here. \- Will be submitting an...
Source: Meeting Notes recrrk2ZhNpQpH2g3
RAW NOTES: \- Raise \- She needs to follow-up \- 125K have signed the SAFEs; all have wired the money as well \- The remaining 37.5K \- Three remaining open conversations; two likely on the lower end (maybe at the 5K level) \- Ernie could do 20-30K \- Mostly friends and friends of friends \- What...
Source: Meeting Notes recW4HS0aaglp3I6T
Link to transcription of call with BRT and Miles: <https://otter.ai/u/wDpcOCaLZQCE5elCdkx9FzjaabM?utm_source=copy_url>
Source: Meeting Notes recXIdNDY9nTdtSaw